ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,283.36
-1.01%
Dow Jones
40,347.97
-1.21%
Gold vs US Dollar
2,446.32
0.02%
Brent Oil
80.01
-1.84%
Bitcoin
64,804.57
0.32%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Harvard Bioscience Inc (HBIO)

  7. Harvard Bioscience Inc (HBIO) News

Harvard Bioscience (HBIO)

Harvard Bioscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HBIO
DateTimeSourceHeadlineSymbolCompany
14/06/202421:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
07/06/202421:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
06/06/202421:05GlobeNewswire Inc.Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024NASDAQ:HBIOHarvard Bioscience Inc
29/05/202422:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:HBIOHarvard Bioscience Inc
23/05/202421:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
23/05/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
23/05/202421:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
23/05/202421:05GlobeNewswire Inc.Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024NASDAQ:HBIOHarvard Bioscience Inc
16/05/202421:05GlobeNewswire Inc.Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual ConferenceNASDAQ:HBIOHarvard Bioscience Inc
14/05/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HBIOHarvard Bioscience Inc
07/05/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HBIOHarvard Bioscience Inc
07/05/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HBIOHarvard Bioscience Inc
07/05/202412:00GlobeNewswire Inc.Harvard Bioscience Announces First Quarter 2024 Financial ResultsNASDAQ:HBIOHarvard Bioscience Inc
29/04/202413:45GlobeNewswire Inc.Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ETNASDAQ:HBIOHarvard Bioscience Inc
09/04/202414:00GlobeNewswire Inc.Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in GrowthNASDAQ:HBIOHarvard Bioscience Inc
11/03/202412:00GlobeNewswire Inc.Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech ConferenceNASDAQ:HBIOHarvard Bioscience Inc
07/03/202422:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:HBIOHarvard Bioscience Inc
07/03/202421:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
07/03/202421:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
07/03/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HBIOHarvard Bioscience Inc
07/03/202412:00GlobeNewswire Inc.Harvard Bioscience Announces Fourth Quarter 2023 Financial ResultsNASDAQ:HBIOHarvard Bioscience Inc
06/03/202413:30GlobeNewswire Inc.Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology MeetingNASDAQ:HBIOHarvard Bioscience Inc
27/02/202422:10GlobeNewswire Inc.Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ETNASDAQ:HBIOHarvard Bioscience Inc
14/02/202421:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HBIOHarvard Bioscience Inc
14/02/202414:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HBIOHarvard Bioscience Inc
14/02/202413:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HBIOHarvard Bioscience Inc
05/01/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HBIOHarvard Bioscience Inc
03/01/202422:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
03/01/202422:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HBIOHarvard Bioscience Inc
20/11/202321:40GlobeNewswire Inc.Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023NASDAQ:HBIOHarvard Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:HBIO

Your Recent History

LSE
GDR
Genedrive
LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
MTRO
Metro Bank
LSE
UKOG
Uk Oil & Gas
LSE
SOLG
Solgold
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
GKP
Gulf Keystone Petroleum
LSE
VAST
Vast Resources
LSE
ENET
Ethernity Networks
LSE
RR.
Rolls-royce
LSE
GWMO
Great Western Mining
LSE
KRS
Keras Resources
LSE
CYAN
Cyanconnode
LSE
TXP
Touchstone Exploration
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved